Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer.
Lee SH, Mizutani N, Mizutani M, Luo Y, Zhou H, Kaplan C, Kim SW, Xiang R, Reisfeld RA.
Lee SH, et al. Among authors: kim sw.
Cancer Immunol Immunother. 2006 Dec;55(12):1565-74. doi: 10.1007/s00262-006-0155-5. Epub 2006 Mar 25.
Cancer Immunol Immunother. 2006.
PMID: 16565828
Free PMC article.